AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism
Top Cited Papers
Open Access
- 16 September 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (41) , 36106-36128
Abstract
Targeting therapeutic nanoparticles to the brain poses a challenge due to the restrictive nature of the blood-brain barrier (BBB). Here we report the development of mRNA-loaded lipid nanoparticles (LNPs) functionalized with BBB-interacting small molecules, thereby enhancing brain delivery and gene expression. Screening brain-targeted mRNA-LNPs in central nervous system (CNS) in vitro models and through intravenous administration in mice demonstrated that acetylcholine-conjugated LNPs achieved superior brain tropism and gene expression, outperforming LNP modifications with nicotine, glucose, memantine, cocaine, tryptophan, and other small molecules. An artificial intelligence (AI)-based model designed to predict the BBB permeability of small-molecule ligands showed strong alignment with our experimental results, providing in vivo validation of its predictive capacity. Cell-specific biodistribution analysis in Cre-reporter Ai9 mice showed that acetylcholine-functionalized LNPs preferentially transfected neurons and astrocytes following either intravenous or intracerebral administration. Mechanistic studies suggest that acetylcholine-LNP uptake is mediated by the functional engagement of acetylcholine receptors (AchRs) followed by endocytosis, which synergistically enhances intracellular mRNA delivery. Moreover, acetylcholine-LNPs successfully crossed a human BBB-on-a-chip model, enabling transgene expression in human iPSC-derived neurons. Their effective penetration and transfection in human brain organoids further support their potential activity in human-based systems. These findings establish a predictive and modular framework for engineering CNS-targeted LNPs, advancing precision gene delivery for brain disorders.Keywords
Funding Information
- European Research Council (101040128, 101089009, 101170349, 851765)
- Israel Science Foundation (1384/21, 1385/21, 1881/21, 1934/23, 2141/20)
- H2020 Marie Sklodowska-Curie Actions (101007804, 101086329)
- Azrieli Foundation
- Teva Pharmaceutical Industries
- Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology
- Baroness Ariane de Rothschild Women Doctoral Program from the Edmond de Rothschild Foundation
- BrightFocus grant (A2022029S)
- NIH Grant (1R21AG074846-01A1)
- Mallat Family Foundation
- PRISM - 2BCured
- Rappaport - Technion Integrated Cancer Center
- Lorry I. Lokey Interdisciplinary Center for Life Sciences & Engineering (LS&E)
- Ministry of Innovation, Science and Technology, Israel (1001576154, 317351, 8-2175)
- Diane Sherman Prize for Medical Innovation for a Better World
- Volkswagen Stiftung: Forschungskooperation Niedersachsen-Israel
- The Aufzien Family Center for the Prevention and Treatment of Parkinson?s Disease at Tel Aviv University
- Michael J. Fox Foundation (MJFF-022407)
- VATAT Scholarship Program
- Ben Barres Early Career award from the Chan Zuckerberg Initiative (CZI)
- Unger Family Fund
- Biomedical Core Facility (BCF)
- Innovation Authority ?BioChip?
- Levinson Family Recruitment Fund (ATS 11647)
- The Louis Family Fund for Targeted Drug Delivery & Personalized Medicine Technologies (ATS 11948)
This publication has 100 references indexed in Scilit:
- Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's DiseaseAdvanced Materials, 2023
- Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid NanoparticlesAdvanced Science, 2023
- Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease TherapySmall, 2022
- Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian CancerSmall, 2021
- Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directionsMedicinal Research Reviews, 2020
- Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering NanomedicineAdvanced Healthcare Materials, 2020
- Transcription Factor–Mediated Differentiation of Human iPSCs into NeuronsCurrent Protocols in Cell Biology, 2018
- Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling Framework to Discover Drug Biodistribution Mechanisms in vivoJournal of Pharmaceutical Sciences, 2012
- Microglia and multiple sclerosisJournal of Neuroscience Research, 2005
- Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administrationSynapse, 2004